Company Overview
A clinical-stage biotechnology company recently established through a reverse merger and restructuring, with a current headcount of fewer than 20 employees. The company is focused on developing therapies for autoimmune and chronic inflammatory diseases.
The pipeline is anchored by a next-generation, best-in-class potential BTK inhibitor, advancing toward Phase II trials in (planned initiation in early 2026). The company is supported by prior fundraising and is currently conducting a new financing round with strong investor connections.
Core functions are already in place across bioanalysis, translational research, nonclinical development, and CMC.
Role Overview
The company is seeking an experienced clinical development leader to provide hands-on operational and scientific leadership as the BTK inhibitor program advances into Phase II. This position is designed to bridge a current leadership gap, as existing senior executives are focused on strategic rather than day-to-day execution.
Responsibilities
- Depending on experience, leads or represents the clinical function in multifunctional project and study teams.
- Stays abreast of internal and external developments, trends and other dynamics relevant to the work of Clinical Development to maintain, at all times, a fully current view and perspective of internal/external influences and/or implications for the pipeline.
- Maintains the highest standards and levels of scientific and clinical knowledge in chronic inflammatory and autoimmune disease.
- Acts as the primary sponsor medical monitor for assigned studies and works with external vendors and internal functions to ensure the highest standard of data quality and medical oversight.
- Accountable for CDP execution: objectives and deliverables are consistently accomplished in a timely, on-target and high-quality manner within budget guidance.
- Designs clinical studies and develops protocols in alignment with the strategies set by the Portfolio Management Committee.
- Supports clinical operations, clinical research organizations (CROs), etc. by acting as a point-of-contact for questions, other communications, and interactions regarding assigned studies.
- Acts as clinical lead in the development of study analytics, medical monitoring plans, safety management plans and data management plans.
- Collaborates with relevant teams and other groups to measure and monitor study progress against objectives and plans, including any variances, and proactively communicates any issues, challenges and potential strategies for resolution.
- Collaborates with drug safety representatives and others in the development of the product safety profile.
- Works with regulatory and other internal partners/stakeholders in the completion and submission of regulatory filings and other regulatory documentation.
- Supports others with clinical science information and input for regulatory submissions and other regulatory processes.
- Drives ongoing data generation, review, and communication to inform or enhance the design or interpretation of ECD studies or other programs and recommend new or modified ECD studies in the assigned therapeutic area.
- Completes and/or leads other special projects as assigned.
Qualifications & Experience
- M.D/PhD with relevant medical and research experience in autoimmune and chronic inflammatory disease particularly in Dermatology, Rheumatology, Neurology or Gastroenterology.
- At least 5 years pharma/biotech industry experience in clinical development OR is a recognized clinician-scientist expert in the field with equivalent clinical.
- Comprehensive understanding of product and safety profiles.
- Well-versed in medical aspects of GCP (Good Clinical Practice), ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use), FDA, EMEA, NICE and other relevant guidelines and regulations.
- Preferred: Experience submitting an IND to regulatory authorities in Europe and/or the U.S.
- Preferred: Experience authoring aspects of a global clinical development plan or full clinical study protocol.
- Preferred: Experience publishing results of clinical drug trials in a refereed journal.
Benötigen Sie weitere Hilfe? Greifen Sie zu an einen unserer Mitarbeiter.
Wir sind ein vertrauenswürdiger Partner für jeden Schritt von der Entdeckung bis zur Entwicklung. Egal, wo Sie sich auf Ihrer Reise befinden, wir sind hier, um Ihnen zu helfen, etwas zu bewirken. Wir sind ein vertrauenswürdiger Partner für jeden Schritt von der Entdeckung bis zur Entwicklung. Egal, wo Sie sich auf Ihrer Reise befinden, wir sind hier, um Ihnen zu helfen, etwas zu bewirken. an einen unserer Mitarbeiter.